Does Health-Related Quality of Life Improve for Advanced Pancreas Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

CONTEXT: Gemcitabine for advanced pancreas cancer (APC) is palliative and prognosis is poor, making health-related quality of life (HRQOL) particularly important. OBJECTIVES: We evaluated HRQOL with the EuroQol EQ-5D™, in patients with APC participating in Cancer and Leukemia Group B (CALGB) 80303,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Romanus, Dorothy, Kindler, Hedy L., Archer, Laura, Basch, Ethan, Niedzwiecki, Donna, Weeks, Jane, Schrag, Deborah
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3658140/
https://ncbi.nlm.nih.gov/pubmed/22104618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpainsymman.2011.09.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares